We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




First Dedicated Leaflet Modification Device Enables TAVR in Patients at Risk of Coronary Obstruction

By HospiMedica International staff writers
Posted on 24 Jan 2024
Print article
Image: ShortCut device is designed to provide a safe, simple and effective way to split valve leaflets (Photo courtesy of Pi-Cardia Ltd.)
Image: ShortCut device is designed to provide a safe, simple and effective way to split valve leaflets (Photo courtesy of Pi-Cardia Ltd.)

The field of Transcatheter Aortic Valve Replacement (TAVR) faces a number of unmet challenges. For instance, degenerated valves that require reintervention present a risk of coronary obstruction and coronary access impairment. Moreover, TAVR procedures in native valves present a risk of coronary impairment in a select group of patients. Now, the world’s first dedicated transcatheter leaflet splitting device can enable coronary access and prevent coronary obstruction during TAVI. Designed for safe, simple splitting of single or double leaflets, with short procedural times, it provides complete control over positioning and leaflet splitting location.

Pi-Cardia Ltd.’s (Rehovot, Israel) ShortCut is the world's first dedicated leaflet modification device facilitating valve-in-valve TAVR procedures in patients at risk of coronary obstruction. ShortCut is part of Pi-Cardia's leaflet modification product portfolio, which also includes the ShortCut Mitral for splitting leaflets in patients at risk for left ventricular outflow tract obstruction following Transcatheter Mitral Valve Replacement (TMVR). Pi-Cardia's ShortCut device is designed to provide a safe, simple, and effective way to split valve leaflets: ShortCut Aortic is designed to split leaflets of a pre-existing valve prior to TAVR in patients at risk for coronary obstruction and may assist in preserving coronary access; ShortCut Mitral is designed to split the anterior mitral leaflet prior to TMVR in patients at risk for LVOT obstruction.

Lifetime management of aortic stenardia has received Breakthrough Device Designation from the US Food and Drug Administration for ShortCut and has completed enrollment in the ShortCut Pivotal Study in the US and Europe.

“We are excited to receive this important recognition by the FDA,” said Erez Golan, Pi-Cardia's Chief Executive Officer. “Breakthrough Device Designation is only awarded to technologies that have the potential to provide more effective treatment or diagnosis for life-threatening or irreversible debilitating diseases or conditions, and it may help accelerate our review process with the FDA this year and bring ShortCut to market for the benefit of patients.”

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Patient Monitor
CMS9100PLUS

Print article

Channels

Critical Care

view channel
Image: Detecting heart diseases using AI and the ECG (Photo courtesy of 123RF)

AI Technology Boosts ECG Capabilities for Early Heart Disease Diagnosis

Cardiovascular diseases often remain undetected until a critical event like a heart attack or stroke occurs. Early identification is key to improving outcomes, but the absence of clear symptoms complicates... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.